Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
65.34 USD | +0.83% | -3.27% | -21.74% |
26/04 | Cytokinetics Appoints Sung Lee as CFO | MT |
26/04 | Cytokinetics, Incorporated Appoints Sung H. Lee as Executive Vice President, Effective as of May 8, 2024 | CI |
Sales 2024 * | 12.11M 1.01B | Sales 2025 * | 165M 13.76B | Capitalization | 6.85B 571B |
---|---|---|---|---|---|
Net income 2024 * | -466M -38.85B | Net income 2025 * | -353M -29.43B | EV / Sales 2024 * | 543 x |
Net cash position 2024 * | 276M 23.02B | Net cash position 2025 * | 606M 50.5B | EV / Sales 2025 * | 37.8 x |
P/E ratio 2024 * |
-14.8
x | P/E ratio 2025 * |
-20.5
x | Employees | 423 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.41% |
Latest transcript on Cytokinetics, Incorporated
1 day | +0.83% | ||
1 week | -3.27% | ||
Current month | -6.80% | ||
1 month | -8.50% | ||
3 months | -21.03% | ||
6 months | +105.86% | ||
Current year | -21.74% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Blum
CEO | Chief Executive Officer | 60 | 01/98/01 |
Kari Loeser
CMP | Compliance Officer | - | 01/21/01 |
Stuart Kupfer
CTO | Chief Tech/Sci/R&D Officer | - | 01/20/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nancy Wysenski
BRD | Director/Board Member | 66 | 20/20/20 |
Edward Kaye
BRD | Director/Board Member | 75 | 20/16/20 |
Santo Costa
BRD | Director/Board Member | 78 | 01/10/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.44% | 0 M€ | 0.00% | - | |
0.39% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 65.34 | +0.83% | 738,059 |
25/24/25 | 64.8 | -3.02% | 1,112,287 |
24/24/24 | 66.82 | +1.91% | 807,781 |
23/24/23 | 65.57 | -1.09% | 1,284,335 |
22/24/22 | 66.29 | -1.87% | 1,184,389 |
Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.74% | 6.85B | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- CYTK Stock